Logos Capital

Life-science focused investment firm that applies disciplined, data-driven investment in biotechnology and therapeutics. The firm combines clinical and commercial underwriting with a proprietary data science platform (Logos Analytics) to evaluate clinical trial probabilities, track events, and manage risk across private and structured public investments.